Bridgefront Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Bridgefront Capital's AMPH Position: Q3 2026 in Review
Bridgefront Capital opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2026: 16,313 shares worth $421K. The stake represents 0.1% of the portfolio and ranks #313 among its holdings.
227 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.
- Bridgefront Capital held 16,313 shares of Amphastar Pharmaceuticals worth $421K as of Q3 2026.
- Amphastar Pharmaceuticals was a new Bridgefront Capital position in Q3 2026.
- Amphastar Pharmaceuticals made up 0.1% of Bridgefront Capital's portfolio in Q3 2026, its #313 holding.
- 227 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.
Based on Bridgefront Capital's 13F filing for Q3 2026, filed 16 Nov 2026.